NURO Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 23:00):

Stats
Объем за сегодня	32 298.00
Средний объем	50 226.00
Рыночная капитализация	8.82M
EPS	$0 ( 2024-02-22 )
Дата следующего отчета о доходах	( $0 ) 2024-05-01
Last Dividend	$1 728.00 ( 2007-03-28 )
Next Dividend	$0 ( N/A )
P/E	-0.710
ATR14	$0.0570 (1.28%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Horowitz Joshua	Buy	16 438	Common Stock
2024-04-18	Horowitz Joshua	Buy	0	Common Stock
2024-04-18	Horowitz Joshua	Sell	0	Common Stock
2024-04-01	Higgins Thomas T	Buy	469	Common Stock
2024-04-01	Higgins Thomas T	Sell	74	Common Stock

INSIDER POWER
54.24
Last 97 transactions
Buy: 971 558 \| Sell: 254 579

NeuroMetrix Inc Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

NeuroMetrix Inc Финансовые показатели

Annual	2023
Выручка:	$5.90M
Валовая прибыль:	$3.95M (66.89 %)
EPS:	$-6.27

FY	2023
Выручка:	$5.90M
Валовая прибыль:	$3.95M (66.89 %)
EPS:	$-6.27

FY	2022
Выручка:	$8.26M
Валовая прибыль:	$5.75M (69.65 %)
EPS:	$-4.90

FY	2021
Выручка:	$8.25M
Валовая прибыль:	$5.92M (71.75 %)
EPS:	$-0.342

Financial Reports:

No articles found.

NeuroMetrix Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

NeuroMetrix Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$1 728.00	2007-03-28
Last Dividend	$1 728.00	2007-03-28
Next Dividend	$0	N/A
Payout Date	2007-04-13
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$1 728.00	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-28)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2007	$1.000	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-1.083	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.298	1.200	-9.95	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.307	1.500	-4.52	-6.78	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	16.81	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	14.92	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.396	1.500	3.36	5.03	[0.2 - 2]
debtRatioTTM	0.0112	-1.500	9.81	-10.00	[0 - 0.6]
interestCoverageTTM	52.63	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	-3.99	2.00	-1.330	-2.66	[0 - 30]
freeCashFlowPerShareTTM	-4.11	2.00	-2.06	-4.11	[0 - 20]
debtEquityRatioTTM	0.0120	-1.500	9.95	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.669	1.000	2.19	2.19	[0.2 - 0.8]
operatingProfitMarginTTM	-1.212	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-25.26	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.275	0.800	-1.497	-1.198	[0.5 - 2]
Total Score				-0.253

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.059	1.000	-0.208	0	[1 - 100]
returnOnEquityTTM	-0.307	2.50	-2.90	-6.78	[0.1 - 1.5]
freeCashFlowPerShareTTM	-4.11	2.00	-1.370	-4.11	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-3.99	2.00	-1.330	-2.66	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0361	1.500	-3.57	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-1.031	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.82

NeuroMetrix Inc

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Обновления в реальном времени для NeuroMetrix Inc [NURO]

Upcoming Earnings Alert

NeuroMetrix Inc Dividend Information - No Dividend Player

Dividend Commentary

Top 10 dividend Companies for NASDAQ

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)